RG Anand v Deluxe Films and Others (1978) 4 SCC 118.[1]
Court: Supreme Court of India
Bench: Justice Syed Murtaza Fazal Ali, Justice P. N. Shinghal and Justice A. D. Koshal
Area of Law: Copyright
Statute Involved: Copyright Act, 1957 (Sections 13 & 14)
Facts
The plaintiff, R.G. Anand, authored the play Hum Hindustani, which addressed the issue of provincialism and promoted national integration. He alleged that representatives of Deluxe Films had viewed his play during discussions for its possible adaptation into a film. Although no agreement was reached, Deluxe Films later released the film New Delhi. Anand claimed that the film substantially copied the plot, theme, and dramatic treatment of his play, thereby infringing his copyright under the Copyright Act, 1957. The Trial Court dismissed the suit, holding that the similarities related only to a common social theme. The matter eventually reached the Supreme Court to determine whether the film constituted copyright infringement.
Legal Issues
- Whether copyright protects an idea or only its expression.
- Whether the film New Delhi substantially reproduced the plaintiff’s play Hum Hindustani.
- Whether similarity in theme, plot, or subject matter alone amounts to copyright infringement.
- What test should be applied to determine infringement of copyright in literary and dramatic works.
Ratio Decidendi
The Supreme Court held that copyright protects only the original expression of an idea and not the idea, theme, plot, or historical fact itself. Infringement arises only when there is substantial and material copying of the author’s expression. The Court formulated the “ordinary spectator test,” observing that if an average viewer, after comparing both works, forms the unmistakable impression that the latter is a copy of the former, infringement is established. Mere similarity in the underlying idea or subject matter is insufficient where the mode of expression, treatment, characters, and presentation are substantially different.
Held
The Supreme Court dismissed the appeal and held that New Delhi did not infringe the plaintiff’s copyright. Although both works addressed provincialism and national integration, they differed significantly in their treatment, characterization, sequence of events, dialogues, and overall presentation. The Court concluded that the similarities were confined to the common idea, which is not protected under copyright law, and therefore no actionable infringement had occurred.
How It Changed the Face of IPR in India
This judgment became the cornerstone of Indian copyright jurisprudence by firmly establishing the idea-expression dichotomy, under which only the expression of an idea,not the idea itself,is protected. It introduced the “ordinary spectator test” for determining substantial similarity, a standard that continues to guide Indian courts in copyright disputes involving literature, films, music, and other creative works. The decision also struck a balance between protecting authors’ rights and preserving creative freedom, ensuring that common themes and ideas remain available for public use while safeguarding original expression. It remains the leading precedent on copyright infringement in India.
Novartis AG v Union of India and Others (2013) 6 SCC 1.[2]
Court: Supreme Court of India
Bench: Justice Aftab Alam and Justice Ranjana Prakash Desai
Area of Law: Patent Law
Statute Involved: Patents Act, 1970 (Sections 2(1)(j), 2(1)(ja) and 3(d)); TRIPS Agreement
Facts
Novartis AG sought a patent in India for the beta crystalline form of Imatinib Mesylate, marketed as Glivec, used to treat chronic myeloid leukemia. The Indian Patent Office rejected the application, holding that the claimed invention was merely a new form of a known substance and failed to satisfy Section 3(d) of the Patents Act, 1970. Novartis challenged the rejection before the Intellectual Property Appellate Board and subsequently before the Supreme Court, arguing that the invention demonstrated enhanced properties and met the requirements of patentability. The dispute centred on whether the modified form exhibited enhanced therapeutic efficacy sufficient to qualify for patent protection under Indian law.
Legal Issues
- Whether the beta crystalline form of Imatinib Mesylate qualified as an “invention” under Sections 2(1)(j) and 2(1)(ja) of the Patents Act, 1970.
- Whether the invention satisfied the enhanced efficacy requirement under Section 3(d).
- Whether improved physicochemical properties alone constitute “enhanced therapeutic efficacy.”
- Whether the rejection of the patent was consistent with India’s obligations under the TRIPS Agreement.
Ratio Decidendi
The Supreme Court held that Section 3(d) establishes a heightened patentability threshold for new forms of known pharmaceutical substances to prevent evergreening. It ruled that improved properties such as better flow, stability, or bioavailability do not by themselves establish enhanced therapeutic efficacy unless they demonstrably improve the drug’s therapeutic effect. Since Novartis failed to prove that the beta crystalline form of Imatinib Mesylate produced enhanced therapeutic efficacy over the known substance, the invention was not patentable under Section 3(d).
Held
The Supreme Court dismissed Novartis’ appeal and upheld the rejection of its patent application. It held that the beta crystalline form of Imatinib Mesylate did not satisfy the enhanced efficacy requirement under Section 3(d) and therefore did not qualify for patent protection. The Court clarified that Section 3(d) is a valid safeguard against evergreening and is fully consistent with India’s patent regime.
How It Changed the Face of IPR in India
The judgment transformed Indian patent law by giving authoritative interpretation to Section 3(d) and firmly discouraging pharmaceutical evergreening. It reinforced India’s public-health-oriented patent regime by ensuring that patents are granted only for genuine therapeutic innovations rather than minor modifications of existing drugs. The decision balanced incentives for innovation with affordable access to medicines, strengthened India’s compliance with the TRIPS Agreement while preserving statutory flexibilities, and became the leading precedent governing pharmaceutical patentability. It continues to influence patent examination, judicial interpretation, and global debates on access to medicines.
Basmati Rice Case (India v. RiceTec Inc.), Opposition before the United States Patent and Trademark Office against U.S. Patent No. 5,663,484 (1997) granted to RiceTec Inc.[3]
Area of Law: Geographical Indications / Patent Law
Statute Involved: Geographical Indications of Goods (Registration and Protection) Act, 1999; TRIPS Agreement (Articles 22–24)
Facts
In 1997, the USPTO granted RiceTec Inc. a patent relating to certain lines and grains marketed as “Basmati” rice, along with claims concerning breeding methods and characteristics associated with traditional Indian and Pakistani Basmati varieties. The patent raised concerns that RiceTec could monopolize the commercial use of the term “Basmati” in international markets. The Government of India challenged the patent, arguing that the claimed invention lacked novelty and improperly appropriated centuries of traditional knowledge associated with the Indo-Gangetic region. Following re-examination, several patent claims were withdrawn or cancelled, substantially narrowing the scope of the patent and preventing exclusive proprietary rights over traditional Basmati characteristics.
Legal Issues
- Whether RiceTec could obtain patent protection over characteristics associated with traditional Basmati rice.
- Whether the claimed invention lacked novelty and inventive step in light of prior traditional knowledge.
- Whether patent protection could indirectly appropriate a geographical indication.
- Whether traditional agricultural knowledge required stronger international legal protection.
Ratio Decidendi
The dispute demonstrated that patent protection cannot be used to appropriate pre-existing traditional knowledge or naturally occurring characteristics lacking novelty and inventive step. Following India’s challenge, the USPTO concluded that several claims could not be sustained because they were anticipated by prior art and existing knowledge relating to traditional Basmati rice. The proceedings reinforced the principle that intellectual property rights must not confer exclusive ownership over products or characteristics long associated with a particular geographical region or traditional community.
Held
Upon re-examination, the USPTO cancelled or significantly amended most of RiceTec’s original patent claims. Although the patent was not entirely revoked, its scope was substantially restricted, preventing RiceTec from asserting broad proprietary rights over traditional Basmati rice. India’s challenge was therefore largely successful in preserving the identity and reputation of Basmati as a product originating from the Indian subcontinent.
How It Changed the Face of IPR in India
The Basmati dispute became a turning point in India’s intellectual property policy by highlighting the vulnerability of traditional knowledge and geographically distinctive products to biopiracy. It accelerated the enactment and implementation of the Geographical Indications of Goods (Registration and Protection) Act, 1999, strengthened India’s strategy for protecting geographical indications internationally, and encouraged systematic documentation of traditional knowledge to prevent misappropriation. The dispute also shaped India’s approach in global IPR negotiations, reinforcing the importance of safeguarding indigenous resources and cultural heritage through stronger legal mechanisms.
Mannu Bhandari v Kala Vikas Pictures Pvt Ltd and Another AIR 1987 Del 13.[4]
Court: Delhi High Court
Bench: Justice S. B. Wad
Area of Law: Copyright Law
Statute Involved: Copyright Act, 1957
Facts
Renowned Hindi author Mannu Bhandari assigned the filming rights of her novel Aap Ka Bunty to Kala Vikas Pictures Pvt. Ltd., which produced the film Samay Ki Dhara. Bhandari alleged that the film substantially distorted the novel’s theme, characters, and message, thereby harming her honour and literary reputation. She sought a permanent injunction restraining the film’s exhibition, contending that the alterations violated her moral rights under Section 57 of the Copyright Act, 1957. Although the parties eventually settled the dispute, they requested the Delhi High Court to pronounce on the scope of an author’s moral rights due to the absence of judicial precedent on the issue.
Legal Issues
- Whether an author retains moral rights under Section 57 after assigning copyright.
- Whether distortion or mutilation of a literary work in its film adaptation infringes the author’s moral rights.
- Whether an assignee’s right to adapt a work is subject to the author’s right to protect their honour and reputation.
- What is the scope of protection afforded under Section 57 of the Copyright Act, 1957.
Ratio Decidendi
The Delhi High Court held that an author’s moral rights under Section 57 are independent of economic rights and survive even after the assignment of copyright. While reasonable modifications are permissible in adapting a literary work into a film, such changes cannot distort, mutilate, or fundamentally alter the original work in a manner prejudicial to the author’s honour or reputation. The Court emphasized that copyright law protects not only commercial interests but also the author’s creative integrity and personality.
Held
Although the parties settled and the suit was withdrawn, the Delhi High Court interpreted Section 57 and affirmed that authors retain enforceable moral rights despite assigning copyright. It held that adaptation rights do not authorize alterations that distort the essence of the original work or prejudice the author’s honour or reputation. The Court thus clarified the legal scope of moral rights under Indian copyright law.
How It Changed the Face of IPR in India
The decision is regarded as the first authoritative judicial exposition of moral rights under Section 57 of the Copyright Act. It established that authors retain the right to preserve the integrity of their works even after assigning economic rights, thereby distinguishing moral rights from copyright ownership. The judgment significantly strengthened the protection of authors, writers, and artists against prejudicial modifications of their works and has since served as a foundational precedent in Indian copyright jurisprudence concerning the integrity and attribution of creative works.
Yahoo! Inc v Akash Arora and Another 78 (1999) DLT 285.[5]
Court: Delhi High Court
Bench: Justice M. K. Sharma
Area of Law: Trademark Law / Domain Name Protection
Statute Involved: Trade and Merchandise Marks Act, 1958 (Sections 27 & 29); Law of Passing Off
Facts
The plaintiff, Yahoo! Inc., operated the globally renowned search engine and internet portal under the trademark and domain name “Yahoo!”. The defendant, Akash Arora, launched a website under the domain name “Yahooindia.com”, offering services similar to those of Yahoo!. The plaintiff contended that the defendant’s domain name was deceptively similar and likely to mislead internet users into believing that the website was associated with Yahoo!. Consequently, Yahoo! Inc. instituted a suit before the Delhi High Court seeking a permanent injunction restraining the defendant from using the impugned domain name on the ground of passing off and trademark infringement.
Legal Issues
- Whether a domain name is entitled to protection equivalent to a trademark.
- Whether the use of “Yahooindia.com” amounted to passing off.
- Whether deceptive similarity in domain names is sufficient to cause consumer confusion.
- Whether prior international reputation and goodwill are protectable in India.
Ratio Decidendi
The Delhi High Court held that a domain name performs the same source-identifying function as a trademark and is therefore entitled to legal protection under the law of passing off. The Court observed that internet users are likely to associate deceptively similar domain names with the original proprietor, resulting in confusion and diversion of business. It emphasized that even if the parties operate in different jurisdictions, the global accessibility of the internet necessitates protection of established goodwill and reputation against deceptive use.
Held
The Delhi High Court granted an interim injunction restraining the defendant from using the domain name “Yahooindia.com” or any other deceptively similar mark. The Court held that the defendant’s use constituted passing off and was likely to deceive internet users into believing that the website was affiliated with Yahoo! Inc. The plaintiff established a strong prima facie case based on its prior reputation and goodwill.
How It Changed the Face of IPR in India
This judgment marked the beginning of cyber trademark jurisprudence in India by recognizing that domain names are valuable intellectual property deserving the same protection as trademarks. It extended the common law doctrine of passing off to the digital environment, enabling courts to curb cybersquatting and deceptive online practices. The decision laid the foundation for subsequent domain name disputes, influenced later landmark cases such as Satyam Infoway Ltd. v. Sifynet Solutions Pvt. Ltd.[6], and significantly strengthened trademark protection in the rapidly evolving digital economy.
This article has been researched and prepared by Shruti Sahu, Legal Research Intern at LegalRath.
[1] https://api.sci.gov.in/jonew/judis/5032.pdf
[2] https://cdnbbsr.s3waas.gov.in/s3ec0490f1f4972d133619a60c30f3559e/documents/aor_notice_circular/29.pdf
[3] Note: This is not a reported judicial decision. It was an administrative patent dispute resolved through re-examination proceedings before the USPTO.
Pavithra. K, ‘Safeguarding heritage: basmati rice dispute (india v. ricetec inc. 1997)’ (2025) 3(2) LawFoyer International Journal of Doctrinal Legal Research (LIJDLR) 573,
https://doi.org/10.70183/lijdlr.2025.v03.62
[4] https://indiankanoon.org/doc/331111/
[5] https://indiankanoon.org/doc/1741869/
[6] Satyam Infoway Ltd v Sifynet Solutions Pvt Ltd (2004) 6 SCC 145.